Details of Disease

General Information of Disease (ID: DISDOS6S)

Disease Name Small intestine lymphoma
Synonyms
small intestine lymphoma; small intestinal lymphoma; small bowel lymphoma; primary small intestinal lymphoma; lymphoma of the small intestine; lymphoma of the small bowel; lymphoma of small intestine; lymphoma of small bowel
Definition A non-Hodgkin or Hodgkin lymphoma that arises from the small intestine.
Disease Hierarchy
DISVHFK0: Small intestine cancer
DISFMRBU: Gastrointestinal lymphoma
DISN6V4S: Lymphoma
DISDOS6S: Small intestine lymphoma
Disease Identifiers
MONDO ID
MONDO_0001852
UMLS CUI
C0278805
MedGen ID
82986
SNOMED CT ID
449074003

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 8 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Fludarabine DMVRLT7 Approved Small molecular drug [1]
Lenalidomide DM6Q7U4 Approved Small molecular drug [2]
Mycophenolate mofetil DMPQAGE Approved Small molecular drug [3]
Mycophenolic acid DMRBMAU Approved NA [4]
Rituximab DM1YVZT Approved Antibody [5]
Tacrolimus DMZ7XNQ Approved Small molecular drug [6]
Thalidomide DM70BU5 Approved Small molecular drug [7]
Vidarabine DM0N85H Approved Small molecular drug [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
CASP8AP2 OTTWT68S Strong Genetic Variation [9]
------------------------------------------------------------------------------------

References

1 Fludarabine FDA Label
2 Lenalidomide FDA Label
3 Mycophenolate mofetil FDA Label
4 A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
5 Metachronous primary cancer of the tongue and malignant lymphoma of the small intestine: A case report. Medicine (Baltimore). 2021 Feb 19;100(7):e24806.
6 Tacrolimus FDA Label
7 Thalidomide FDA Label
8 Vidarabine FDA Label
9 Development and internal validation of a risk scoring system for gastrointestinal events requiring surgery in gastrointestinal lymphoma patients.J Gastroenterol Hepatol. 2019 Apr;34(4):693-699. doi: 10.1111/jgh.14452. Epub 2018 Sep 19.